Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.

Contemporary estrogen-progestin contraceptives are associated with an increased risk for ischemic stroke and myocardial infarction.

The US FDA has approved a new drug application for a tablet version of Evrysdi (risdiplam) for people living with spinal muscular atrophy.

A recent study finds that women with epilepsy may have offspring with decreased bone metabolism and lower birth weight.

Certain metabolic factors are associated with the development of chronic musculoskeletal pain, including higher BMI and the presence of diabetes.

The use of combined oral contraceptives may delay the onset of hidradenitis suppurativa among women and may improve disease severity.

For infants born before 34 weeks of gestation and with a birth weight <1,000 g, probiotics are associated with reduced mortality.

Gastroesophageal symptoms significantly impact methotrexate dosages and disease activity among patients with RA.

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Sildenafil was effective for reducing diastolic dysfunction and altered ejection fraction among patients with SSc.

Federal funding for medical research has dropped by $1 billion this year, raising alarm among universities, medical centers, and lawmakers.

Higher leptin levels were associated with chronic widespread pain among patients with RA, even after adjusting for age, BMI, and sex.